UNIVERSITY OF SOUTHERN CALIFORNIA
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1880-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://startusc.com
Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2004-06-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 28
- Registration Number
- NCT00003085
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-06-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 16
- Registration Number
- NCT00003009
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma
- Conditions
- Recurrent Intraocular MelanomaRecurrent MelanomaStage IIIC MelanomaCiliary Body and Choroid Melanoma, Small SizeStage IIIA MelanomaStage IIIB Intraocular MelanomaExtraocular Extension MelanomaIris MelanomaCiliary Body and Choroid Melanoma, Medium/Large SizeStage IIIB Melanoma
- Interventions
- Biological: gp100 antigenBiological: tyrosinase peptideBiological: recombinant MAGE-3.1 antigenBiological: multi-epitope melanoma peptide vaccineBiological: incomplete Freund's adjuvantOther: laboratory biomarker analysis
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 42
- Registration Number
- NCT00085189
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
IM-862 in Treating Patients With Recurrent Ovarian Cancer
- Conditions
- Ovarian Cancer
- First Posted Date
- 2004-06-03
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 43
- Registration Number
- NCT00003773
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
- Conditions
- Intraocular MelanomaMelanoma (Skin)
- First Posted Date
- 2004-05-26
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 15
- Registration Number
- NCT00005841
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸City of Hope National Medical Center, Los Angeles, California, United States
Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2004-03-22
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 48
- Registration Number
- NCT00003274
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2004-02-26
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 18
- Registration Number
- NCT00006037
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
- Conditions
- Ovarian Cancer
- First Posted Date
- 2003-09-24
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 35
- Registration Number
- NCT00003449
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 25
- Registration Number
- NCT00006113
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery
- Conditions
- Melanoma (Skin)Intraocular Melanoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 19
- Registration Number
- NCT00025181
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States